Five key biomarkers involved in the pathogenesis of PAH (RRAS, BECN1, MFN1, HIF1A, TAX1BP1) were ultimately identified, providing new evidence for understanding the molecular mechanisms of PAH and developing diagnostic/therapeutic strategies. This evidence concerns the gene MFN1 and pulmonary arterial hypertension.